The role of ERK1/2 in 15-HETE-inhibited apoptosis in pulmonary arterial smooth muscle cells

Journal of Receptors and Signal Transduction

Volumn 31, Issue 1, 2011, Pages 45-52

  Jiang, Jing ^a   Wang, Shuang ^a   Wang, Zhigang ^a   Ma, Jun ^a   Liu, Shulin ^a   Li, Weiyang ^b   Zhu, Daling ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

15 Hydroxyeicosatetrenoic acid; Apoptosis; ERK; Pulmonary artery muscle smooth cells

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; PROTEIN BCL 2; TENSIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CHROMOSOME ANALYSIS; GENE DELETION; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; SEQUENCE HOMOLOGY; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL SURVIVAL; ENZYME ACTIVATION; HYDROXYEICOSATETRAENOIC ACIDS; IN SITU NICK-END LABELING; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; PULMONARY ARTERY; RATS; RATS, WISTAR; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 78650766586     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2010.512013     Document Type: Article

References (29)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004, 351, 1425-1436.
2. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 2004, 68, 75-103.
3. Pidgeon GP, Tamosiuniene R, Chen G, Leonard I, Belton O, Bradford A, Fitzgerald DJ. Intravascular thrombosis after hypoxia- induced pulmonary hypertension: regulation by cyclooxygenase- 2. Circulation 2004, 110, 2701-2707.
4. Rabinovitch M. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 1998, 114, 213S-224S.
5. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003, 285, L740-L754.
6. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995, 270, 14843-14846.
7. Nishida S, Matsuoka H, Tsubaki M, Tanimori Y, Yanae M, Fujii Y, Iwaki M. Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK. Mol Cell Biochem 2005, 269, 109-114.
8. Wang W, Prince CZ, Mou Y, Pollman MJ. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. JBC 2002, 277, 21723-21729.
9. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007, 1773, 1263-1284.
10. Jimmy YCC, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM. RAS/ERK modulates TGFβ-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 2007, 28, 2321-2327.
11. Beck SE, Carethers JM. BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther 2007, 6, 1313-1317.
12. Gardai SJ, Whitlock BB, Xiao YQ, Bratton DB, Henson PM. Oxidants inhibit ERK/MAPK and prevent its ability to delay neutrophil apoptosis downstream of mitochondrial changes and at the level of XIAP. J Biol Chem 2004, 279, 44695-44703.
13. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, Jacobs ER. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 2003, 92, 992-1000.
14. Wang S, Wang Y, Jiang J, Wang R, Li L, Qiu Z, Wu H, Zhu D. 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway. Prostaglandins Other Lipid Mediat 2010, 91, 51-60.
15. Lu C, Liu Y, Tang X, Ye H, Zhu D. Role of 15-hydroxyeicosatetraenoic acid in phosphorylation of ERK1/2 and caldesmon in pulmonary arterial smooth muscle cells. Can J Physiol Pharmacol 2006, 84, 1061-1069.
16. Guo L, Tang X, Tian H, Liu Y, Wang Z, Wu H, Wang J, Guo S, Zhu D. Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells. Eur J Pharmacol 2008, 587, 187-195.
17. Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng X, Zhu D. 20- Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol 2008, 588, 9-17.
18. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclindependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur Heart J 1999, 20, 406-420.
19. Chen M, Guerrero AD, Huang L, Shabier Z, Pan M, Tan TH, Wang J. Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem 2007, 282, 33888-33895.
20. Vasudevan KM, Gurumurthy S, Rangnekar VM. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 2004, 24, 1007-1021.
21. Han W, Tang X, Wu H, Liu Y, Zhu D. Role of ERK1/2 signaling pathways in 4-aminopyridine-induced rat pulmonary vasoconstriction. Eur J Pharmacol 2007, 569, 138-144. (Pubitemid 47189561)
22. Chu X, Tang X, Guo L, Bao H, Zhang S, Zhang J, Zhu D. Hypoxia suppresses KV1.5 channel expression through endogenous 15-HETE in rat pulmonary artery. Prostaglandins Other Lipid Mediat 2009, 88, 42-50.
23. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 2004, 95, 830-840.
24. Ekhterae D, Platoshyn O, Krick S, Yu Y, McDaniel SS, Yuan JX. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol, Cell Physiol 2001, 281, C157-C165.
25. Wang X, Gjörloff-Wingren A, Saxena M, Pathan N, Reed JC, Mustelin T. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J Immunol 2000, 164, 1934-1939.
26. Weng LP, Brown JL, Baker KM, Ostrowski MC, Eng C. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 2002, 11, 1687-1696.
27. Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998, 143, 1375-1383.
28. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999, 13, 239-252.
29. Wang G, Ahmad KA, Harris NH, Ahmed K. Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells. Mol Cell Biochem 2008, 316, 91-97.